AP examines HIV microbicides.

Copyright 2009 Advisory Board Business and Kaiser Family Base. All rights reserved.. AP examines HIV microbicides, prep research Try after make an effort to make vaginal creams that could repel the AIDS virus have failed. More than half a dozen research of the so-called Pre-Exposure Prophylaxis [PrEP] are under method among high-risk populations around the world, largely using the drug tenofovir because it tends to cause fewer unwanted effects than many other AIDS medications, the AP writes. Experts are waiting to see the outcomes of clinical trial of ladies who used a gel manufactured from the AIDS drug tenofovir – expected out in July, based on the AP. It’s the first assessment of both strategies, the AP writes. The article includes remarks by Salim Abdool Karim of the Centre for the AIDS Program of Analysis in South Africa at the University of KwaZulu-Natal, who led the pending tenofovir gel research, along with other researchers .The 5th publication entitled, The Dangers of Copper Toxicity Adding to Cognitive Decline in the Ageing Population also to Alzheimer’s Disease,in the June 2009 problem of the Journal of the American College of Diet was published. According to the Copper Hypothesis outlined in the paper by Dr. Brewer, the epidemics of MCI and Advertisement in our population over age 50 is partly due to the ingestion of inorganic copper in normal water and copper products. George J. Brewer, M.D., Adeona’s scientific founder and consultant, remarked, We are beginning to build the peer-examined scientific literature that works with the hypothesis that copper toxicity and zinc insufficiency is normally a hallmark of Alzheimer’s disease and cognitive decline.